Home » Topics » BioWorld

BioWorld
RSS

TRIPLEX COMPLETES $12.2M PRIVATE PLACEMENT

July 24, 1991

CETUS DRUG PORTFOLIO DIFFICULT TO VALUE

July 24, 1991

CETUS TO SELL PCR TECHNOLOGY

July 23, 1991

CHIRON-CETUS MERGER AT A GLANCE

July 23, 1991

BEARISH REACTION TO CETUS-CHIRON DEAL

July 23, 1991

RIBI AMENDS PACT WITH D. BLECH

July 22, 1991

APPOINTMENTS AND ADVANCEMENTS

July 22, 1991

INTERNEURON GETS RIGHTS FOR MELATONIN

July 22, 1991

OLIGONUCLEOTIDES INHIBIT HIV EXPRESSION

July 22, 1991

FDA PANEL GRANTS ddI QUALIFIED APPROVAL

July 22, 1991

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...